Diabetes Innovation Quality of Life 
Cardiometabolic Health Congress
AUGUST 2, 2024
Cardiorenal and metabolic diseases represent a complex constellation of lifestyle factors and health conditions that significantly impact longevity and quality of life. In the United States alone, an estimated 47 million people are affected by cardiorenal metabolic-related risk factors and diseases.
DAIC
DECEMBER 19, 2023
This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.
GEMMS
MAY 22, 2024
In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.
Cardiometabolic Health Congress
JULY 7, 2023
Third and perhaps most important, being able to use what I have learned here in US to make a very small dent to improve the quality of life for communities in low-middle income countries. Second is the ability to be mentored by some great mentors and then being able to mentor our fellows in training and junior faculty. 18-21, 2023.
DAIC
MARCH 25, 2025
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25
DAIC
APRIL 1, 2024
Earlier detection can extend the quality of life with treatments designed to prevent progression. The concepts I wrote in this paper also form the crux of what we are doing here at the Center for Innovation at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Is There Medication for Valvular Heart Disease?
Cardiometabolic Health Congress
AUGUST 8, 2024
Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. Here are four key strategies to achieve this: 1.Shared
Expert insights. Personalized for you.
59 
Let's personalize your content